1009-2501
2010 Issue 7
..............page:821-826
Clinical study on efficacy and security of fixed-dose glipizide/metformin on type 2 diabetes mellitus(DM)
YAO Lu;LV Xiao-feng;JI Xin;ZHANG Jian-li
YAO Lu;LV Xiao-feng;JI Xin;ZHANG Jian-li
..............page:803-808
Advances in study of fluorouracil for implantation and its clinical application in adenocarcinoma
ZAN Pei-xia;YAN Shi-jie
ZAN Pei-xia;YAN Shi-jie
..............page:827-831
Effects of proteasome inhibitor MG-132 on cardiac function and expressions of Hsp70 and CHIP in myocardial infarction rats
ZHANG Xin-min;DAI Cui-lian;TANG Ji-fei;YANG Peng-lin
ZHANG Xin-min;DAI Cui-lian;TANG Ji-fei;YANG Peng-lin
..............page:747-752
Pharmacological mechanism of propofol and its new clinical usage
LIU Qiang;HONG Jiang;LI Xiao-yu
LIU Qiang;HONG Jiang;LI Xiao-yu
..............page:836-840
Protective effect of MIF siRNA mediated by lipid microbubbles on acute lung injury in mice
JIANG Yong-nan;MO Hong-ying;CHEN Jian-hai
JIANG Yong-nan;MO Hong-ying;CHEN Jian-hai
..............page:737-742
Effects of crocetin on the proliferation and differentiation of 3T3-L1 preadipocyte
ZHANG Xiao-ming;QIAN Zhi-yu;JI Hui;YANG Li-na;YANG Ru-hui;SONG Lei
ZHANG Xiao-ming;QIAN Zhi-yu;JI Hui;YANG Li-na;YANG Ru-hui;SONG Lei
..............page:753-757
Evaluation of promoting effects of transdermal enhancers with principle components analysis method
CHEN Yan-fen;WANG Tong-ren;WANG Hui;LIANG Qing
CHEN Yan-fen;WANG Tong-ren;WANG Hui;LIANG Qing
..............page:788-793
Comparison of the inhibitory effect on HBV replication by siRNA and lamivudine in HepG2.2.15 cells
LI Gui-qiu;CHEN Shu-lan;CUI Lan-ying;ZHAO Jin-ying;LUO Wen-tao;LU Juan
LI Gui-qiu;CHEN Shu-lan;CUI Lan-ying;ZHAO Jin-ying;LUO Wen-tao;LU Juan
..............page:727-731
Improvement effect of salvianolate on small intestinal mucosal barrier in cirrhotic rats
YANG Dan-hong;YE Zai-yuan;HE Xu-jun;ZHANG Qin;ZHOU Wei-ming;XU Wen-juan;LV Huo-xiang
YANG Dan-hong;YE Zai-yuan;HE Xu-jun;ZHANG Qin;ZHOU Wei-ming;XU Wen-juan;LV Huo-xiang
..............page:758-763
..............page:736,774
Effect of tirofiban on the plasma inflammatory factors of P-selectin,IL-6 and IL-1β in vitro
XIE Shuang-feng;YIN Song-mei;NIE Da-nian;LI Yi-qing;XIAO Jie;MA Li-ping;WANG Xiu-ju;WANG Jing-feng
XIE Shuang-feng;YIN Song-mei;NIE Da-nian;LI Yi-qing;XIAO Jie;MA Li-ping;WANG Xiu-ju;WANG Jing-feng
..............page:732-736
Evaluation of sustained-release effect on Compound Danshen Skeleton Sustained-Release Tablet by pharmacodynamics method
XU Guo-liang;TANG Xi-lan;SHAN Yi-min;ZHANG Qi-yun;ZHENG Qin;YANG Ming
XU Guo-liang;TANG Xi-lan;SHAN Yi-min;ZHANG Qi-yun;ZHENG Qin;YANG Ming
..............page:794-798
Inhibitory action of crocetin on the expression of E-selectin in bovine endothelial cells induced by advanced glycation end products
XIANG Min;ZHOU Cheng-hua;QIAN Zhi-yu
XIANG Min;ZHOU Cheng-hua;QIAN Zhi-yu
..............page:764-769
A rapid and sensitive LC-MS/MS method for determination of valsartan in human plasma
LI Ling;TAN Zhi-rong;CHEN Yao;ZHOU Gan;GUO Dong;YAN Jin;YANG Guo-ping;OUYANG Dong-sheng
LI Ling;TAN Zhi-rong;CHEN Yao;ZHOU Gan;GUO Dong;YAN Jin;YANG Guo-ping;OUYANG Dong-sheng
..............page:809-813
Effect of puerarin on contents of MCP-1,TNF-α and pulmonary ultrastructure after thrombolytic therapy in rabbits with acute pulmonary embolism
JIANG Qin-hua;CHEN Yan-fan;XU Xian-rong;XU Wen;LI Guo-ping;WANG Liang-xing;CHEN Shao-xian
JIANG Qin-hua;CHEN Yan-fan;XU Xian-rong;XU Wen;LI Guo-ping;WANG Liang-xing;CHEN Shao-xian
..............page:781-785
Effect of nebivolol on circle and aortic renin-angiotensin system in spontaneously hypertensive rats
WANG Yan;ZHANG Ming-sheng;LIU Yu;CHEN Min
WANG Yan;ZHANG Ming-sheng;LIU Yu;CHEN Min
..............page:770-774
she du xue ning mei zai lu nao shou shu bing ren zhong zhi xue liao xiao guan cha
li hai ping ; huang lu mao ; yong cheng ming ; yang dai ming
li hai ping ; huang lu mao ; yong cheng ming ; yang dai ming
..............page:786-787
Research advance on P-glycoprotein inhibitors and the structure-activity relationship
WEN Xiao-zhou;ZHOU Fang;WU Xiao-lan;WANG Guang-ji
WEN Xiao-zhou;ZHOU Fang;WU Xiao-lan;WANG Guang-ji
..............page:814-820
Clinical application advancement of pulmonary surfactant
XU Guo-cheng;LI Zhi-qi
XU Guo-cheng;LI Zhi-qi
..............page:832-835
Auto statistical report for trough/peak ratio index in the evaluation of ambulatory blood pressure monitoring by SAS software
XU Lin-yong;ZHANG Wei;ZENG Fang;FU Chen-chao;ZHAO Li;ZHAO Xiao-hua;SUN Zhen-qiu
XU Lin-yong;ZHANG Wei;ZENG Fang;FU Chen-chao;ZHAO Li;ZHAO Xiao-hua;SUN Zhen-qiu
..............page:798-802
Effect of Urotensin Ⅱ on the apoptosis of human lung adenocarcinoma A549 cells and the underlying mechanism
ZHOU Cheng-hua;SONG Zheng;XING Shu-hua;WU Yu-qing;ZHENG Jun-nian;PEI Dong-shang
ZHOU Cheng-hua;SONG Zheng;XING Shu-hua;WU Yu-qing;ZHENG Jun-nian;PEI Dong-shang
..............page:742-746
Effects of Danshen Injection on the activity of rabbit CYP1A2,CYP2D6 and CYP3A4 in vivo
LIU Gao-feng;ZHEN Li-mian;HUANG Li-jun
LIU Gao-feng;ZHEN Li-mian;HUANG Li-jun
..............page:775-780
Protective effects of icariin on cerebral mitochondria function in SAMP8 mice
WU Man-gang;HE Xiao-li;QIANG Gui-fen;SHI Li-li;LI Xiao-xiu;ZU Mian;LIU Dong-hua;BI Ming-gang;DU Guan-hua
WU Man-gang;HE Xiao-li;QIANG Gui-fen;SHI Li-li;LI Xiao-xiu;ZU Mian;LIU Dong-hua;BI Ming-gang;DU Guan-hua
..............page:721-726